References
- Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med 1969;280:638-41. https://doi.org/10.1056/NEJM196903202801204
- Kennedy MJ, Volz PA. Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immun 1985;49:654-63.
- Bodey GP. Candidiasis in cancer patients. Am J Med 1984;77:13-9.
- Kennedy MJ, Volz PA. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia 1985;23:265-73. https://doi.org/10.1080/00362178585380391
- Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 2000;174:422-8. https://doi.org/10.1007/s002030000222
- Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 2005;230:155-70. https://doi.org/10.1177/153537020523000302
- Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998;21:335-9.
- Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TA. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000;72:395-400. https://doi.org/10.1093/ajcn/72.2.395
- Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2003;54:68-78. https://doi.org/10.1002/pros.10137
- Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 2004;70:1188-95. https://doi.org/10.1095/biolreprod.103.023713
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. Document M27-A. Wayne: PA: National Committee for Clinical Laboratory Standards;1997.
- Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ, Rex JH. Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility. J Clin Microbiol 1999;37:2755-9.
- Henry-Stanley MJ, Garni RM, Wells CL. Adaptation of FUN-1 and Calcofluor white stains to assess the ability of viable and nonviable yeast to adhere to and be internalized by cultured mammalian cells. J Microbial Methods 2004;59:289-92. https://doi.org/10.1016/j.mimet.2004.07.001
- Rapp RP. Changing strategies for the management of invasive fungal infections. Pharmacotherapy 2004;24(2 Pt 2):4S-28S. https://doi.org/10.1592/phco.24.3.4S.33151
Cited by
- Synergistic Antifungal Effect of Glabridin and Fluconazole vol.9, pp.7, 2014, https://doi.org/10.1371/journal.pone.0103442
- vol.2015, pp.1741-4288, 2015, https://doi.org/10.1155/2015/287693
- Design and development of a topical dosage form for the convenient delivery of electrospun drug loaded nanofibers vol.5, pp.65, 2015, https://doi.org/10.1039/C5RA04438C
- Equol, a Clinically Important Metabolite, Inhibits the Development and Pathogenicity of Magnaporthe oryzae, the Causal Agent of Rice Blast Disease vol.22, pp.11, 2017, https://doi.org/10.3390/molecules22101799
- Methylene Blue-Loaded Dissolving Microneedles: Potential Use in Photodynamic Antimicrobial Chemotherapy of Infected Wounds vol.7, pp.4, 2015, https://doi.org/10.3390/pharmaceutics7040397